We have finally made it to the break even year (I.e. Q1 earnings will be a good sign of this).
Finally, we have a fantastic new product in NIAGEN (that I physically take).
These combined with the wave of academic research comming in is like a perfect storm to the upside.
Profitability, will allow new investors to invest, an exciting new product will attract new investors, a valid new product will solidify CDXC as a solid company worthy to move beyond the OTC.
Hi Many good to see you amungst the crazy pumpers. I doubt a deal could happen without a press release, are there not clear rules about that? Good luck as always. Things are a lot better these days, can't wait for Friday's first quarter earnings.
You're saying it wrong. It's Wingardium LeviOsa, not Wingardium LevioSA. Copying my own comment back to me, must be some sort of new crazy psychology that I'll have no part of. Think about the benefits of Nicotinamide Riboside, if you can.